SCHEDULE 13G/A: T. Rowe Price Discloses 4.6% Stake in Molina Healthcare Inc.
Beneficial Ownership Disclosure
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in Molina Healthcare Inc. as of December 31, 2024.
Summary
- T. Rowe Price Associates, Inc. reported beneficial ownership of 2,621,607 shares of Molina Healthcare Inc. common stock.
- This ownership represents 4.6% of the total class of Molina Healthcare Inc. common stock.
- T. Rowe Price Associates, Inc. holds sole voting power over 2,542,842 shares and sole dispositive power over 2,620,701 shares.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating a change from a previous filing.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Molina Healthcare Inc.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of a significant institutional ownership stake, indicating continued investment by a major firm in Molina Healthcare. It does not contain negative news about the issuer or suggest any immediate operational changes.
Positives
- T. Rowe Price Associates, Inc., a prominent investment adviser, maintains a significant beneficial ownership of 4.6% in Molina Healthcare Inc., indicating continued institutional investment interest.
Future Outlook
The document is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Molina Healthcare Inc.'s future performance or T. Rowe Price's future investment intentions beyond the standard certification.
Management Comments
- T. Rowe Price Associates, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
This filing indicates a significant institutional holding by T. Rowe Price, a major global asset manager, in Molina Healthcare Inc., a prominent managed healthcare services company. Such disclosures provide transparency into the investment positions of large institutional investors within the healthcare sector.
Stakeholder Impact
- Shareholders: Provides transparency on significant institutional holdings, which can influence investor confidence and market perception of Molina Healthcare Inc.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/14/2025 | Date of signature and filing of the Schedule 13G Amendment No. 2. |
Keywords
Molina Healthcare, T. Rowe Price, Schedule 13G, beneficial ownership, common stock, healthcare, investment adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.